- About Us
- Our Research
- Diseases and conditions
- Research Groups
- Research support and facilities
- Aboriginal and Torres Strait Islander Health
- Our publications
- Participate in our research
- Research highlights
- Research history
- Glossary of research terms
- Support Us
- Why support QIMR Berghofer?
- Ways to help
- Book a tour or guest speaker
- February Appeal
- Our supporters
- Thanks to our donors
- School students
- University students
- News & Events
- Contact Us
- Our Services
- CMV study
- Queensland Pancreatic Cancer Study
- QIMR Berghofer Centre for Immunotherapy and Vaccine Development
|Share on Facebook||Share on Twitter||Share on LinkedIn|
Oesophageal cancer is cancer of the muscular tube that leads from the throat to the stomach. Two different types of cancer affect the oesophagus: squamous cell carcinoma (OSCC – the type of cancer that begins in flat cells lining the oesophagus) and adenocarcinoma (OAC – the type of cancer that begins in cells that make and release mucus and other fluids). There are over 1,200 cases of oesophageal cancer every year in Australia, and most sufferers die within 12 months of diagnosis.
Oesophageal cancer is usually preceded by a condition call Barrett's oesophagus. Barrett’s oesophagus is a condition in which the normal flat-celled (squamous) lining of the oesophagus changes, becoming similar to the glandular tissue that lines the intestine. This change is called metaplasia, which can progress to a more dangerous, pre-cancerous form called dysplasia. In a small number of patients, these changes go on to form oesophageal cancer.
Our researchers are investigating both Barrett's oesophagus and oesophageal cancer in a wide range of areas.
Our research focuses on:
- Investigating the link between irritable bowel disease and Barrett's oesophagus.
- Researching the biochemical and genetic changes that occur within a cell during Barrett's oesophagus and oesophageal cancer, which may lead to a better understanding of treatment options.
Our recent research:
- Developed a clinical risk prediction tool for Barrett's oesophagus, eliminating the need for unnecessary endoscopic procedures.
Research groups involved in oesophageal cancer research: